Ticker > Company >

Archit Organosys share price

Archit Organosys Ltd.

BSE: 524640 SECTOR: Chemicals  16k   46   6

43.83
+0.29 (0.67%)
BSE: 22 Nov 04:00 PM

Price Summary

Today's High

₹ 44.43

Today's Low

₹ 42.68

52 Week High

₹ 63.65

52 Week Low

₹ 35.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

89.94 Cr.

Enterprise Value

111.38 Cr.

No. of Shares

2.05 Cr.

P/E

26.81

P/B

1.36

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  32.24

CASH

4.22 Cr.

DEBT

25.66 Cr.

Promoter Holding

64.65 %

EPS (TTM)

₹  1.63

Sales Growth

-11.42%

ROE

5.3 %

ROCE

7.63%

Profit Growth

-70.79 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-11.42%
3 Year6.2%
5 Year6.15%

Profit Growth

1 Year-70.79%
3 Year-12.64%
5 Year22.05%

ROE%

1 Year5.3%
3 Year14.49%
5 Year10.96%

ROCE %

1 Year7.63%
3 Year15.16%
5 Year12.08%

Debt/Equity

0.4001

Price to Cash Flow

8.82

Interest Cover Ratio

2.7012

CFO/PAT (5 Yr. Avg.)

2.12111197297268

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 64.65 0.00
Jun 2024 64.65 0.00
Mar 2024 63.26 0.00
Dec 2023 62.37 0.00
Sep 2023 62.37 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 21.6458 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.12111197297268.
  • The company has a high promoter holding of 64.65%.

 Limitations

  • The company has shown a poor profit growth of -12.6399178658091% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.1963989280333% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 26.39 24.81 30.99 27 29.54
Total Expenditure 24.28 23.71 30.7 23.96 26.69
Operating Profit 2.11 1.1 0.28 3.05 2.85
Other Income 0.54 0.52 0.74 0.47 0.63
Interest 0.65 0.77 0.64 0.62 0.78
Depreciation 1.49 1.49 1.48 1.49 1.5
Exceptional Items 0 0 3.37 0 0
Profit Before Tax 0.51 -0.64 2.28 1.41 1.2
Tax 0.14 -0.18 0.49 0.41 0.18
Profit After Tax 0.37 -0.46 1.79 1.01 1.02
Adjusted EPS (Rs) 0.18 -0.22 0.87 0.49 0.5

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 76.69 94.51 137.9 127.78 113.19
Total Expenditure 73.12 83.45 121.84 108.88 106.45
Operating Profit 3.57 11.06 16.06 18.9 6.75
Other Income 2.29 0.54 2.5 1.92 2.51
Interest 3.17 3.25 2.44 2.16 2.58
Depreciation 3.47 3.67 4.69 4.88 5.66
Exceptional Items 0 0 0 1.65 3.37
Profit Before Tax -0.79 4.68 11.43 15.44 4.39
Tax 0.01 -0.32 3.19 4.01 1.05
Net Profit -0.8 5.01 8.23 11.43 3.34
Adjusted EPS (Rs.) -0.53 3.33 4.01 5.57 1.63

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 15.02 15.02 20.52 20.52 20.52
Total Reserves 19.09 25.52 31.37 41.33 43.63
Borrowings 12.4 12.11 12.21 14.2 7.63
Other N/C liabilities 0.45 -0.82 1.85 2.3 2.2
Current liabilities 35.66 34.58 39.44 46.15 35.12
Total Liabilities 82.61 86.41 105.39 124.5 109.09
Assets
Net Block 50.42 47.67 45.05 50.46 59.66
Capital WIP 1.08 2.98 12.75 13.79 0.7
Intangible WIP 0 0 0 0 0
Investments 0 0.3 1.4 3.75 5.87
Loans & Advances 0.76 0.99 1.43 1.36 0.52
Other N/C Assets 0 0 0.06 0.16 0
Current Assets 30.36 34.47 44.7 54.98 42.34
Total Assets 82.61 86.41 105.39 124.5 109.09
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.79 4.68 11.43 15.44 4.39
Adjustment 6.08 7.5 6.36 4.48 1.24
Changes in Assets & Liabilities 2.53 -1.05 -5.7 1.26 5.61
Tax Paid -0.08 -0.02 -1.47 -3.15 -1.04
Operating Cash Flow 7.74 11.11 10.62 18.03 10.2
Investing Cash Flow -0.82 -2.87 -11.52 -11.5 -2.26
Financing Cash Flow -8.87 -7.38 2.43 -6.57 -9.13
Net Cash Flow -1.95 0.86 1.54 -0.03 -1.2

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 62.37 62.37 63.26 64.65 64.65
archana kandarp amin 21.30 21.30 22.19 22.19 22.19
archit kandarp amin 7.90 7.90 7.90 8.30 8.30
kandarp krishnakant amin 20.42 20.42 20.42 21.24 21.24
manini suchit amin 2.44 2.44 2.44 2.44 2.44
shimoli archit amin 2.44 2.44 2.44 2.44 2.44
suchit kandarp amin 7.88 7.88 7.88 8.04 8.04
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 37.63 37.63 36.74 35.35 35.35
llp 0.02 0.02 0.02 0.02 0.02

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Archit Organosys - Quaterly Results 8 Aug, 6:08 PM Archit Organosys - Quaterly Results 8 Aug, 6:08 PM Archit Organosys - Quaterly Results 8 Aug, 6:08 PM Archit Organosys reply to clarification sought on significant movement in price 19 Jun, 1:02 PM Archit Organosys informs about disclosure 18 Jun, 5:31 PM Archit Organosys informs about trading window closure 30 Mar, 4:10 PM Archit Organosys gets nod to divest entire 50.01% stake in Novel and Nano Xtreme Solutions 27 Mar, 4:02 PM Archit Organosys - Quaterly Results 14 Feb, 6:28 PM Archit Organosys incorporates subsidiary company 22 Dec, 10:12 AM Archit Organosys submits annual report 10 Aug, 1:38 PM Archit Organosys informs about issuance duplicate share certificate 8 Aug, 2:13 PM Archit Organosys gets nod to transfer 81% stake in Archit Life Science 19 Jun, 9:25 AM Archit Organosys informs about details of loss of certificate 6 Jun, 4:29 PM Archit Organosys - Quaterly Results 12 May, 11:50 PM Archit Organosys - Quaterly Results 12 May, 11:50 PM Archit Organosys informs about board meeting 3 May, 12:23 PM Archit Organosys informs about non-applicability of large corporate entity 28 Apr, 2:01 PM Archit Organosys informs about disclosure 6 Mar, 9:43 AM Archit Organosys informs about disclosure 4 Mar, 4:00 PM Archit Organosys informs about disclosure 25 Feb, 11:26 AM Archit Organosys informs about disclosure 4 Feb, 10:43 AM Archit Organosys - Quaterly Results 13 Jan, 7:48 PM Archit Organosys - Quaterly Results 13 Jan, 7:48 PM Archit Organosys informs about loss of share certificates 29 Dec, 4:20 PM Archit Organosys informs about disclosure 16 Sep, 12:02 PM Archit Organosys incorporates Wholly Owned Subsidiary 3 Sep, 9:24 AM Archit Organosys informs about disclosure 30 Aug, 4:21 PM Archit Organosys informs about disclosure 26 Aug, 10:14 AM Archit Organosys informs about disclosure 30 Jul, 11:08 AM Archit Organosys informs about disclosure 26 Jul, 5:02 PM Archit Organosys gets nod to incorporate new wholly owned subsidiary 26 Jul, 11:18 AM Archit Organosys - Quaterly Results 25 Jul, 5:45 PM Archit Organosys - Quaterly Results 25 Jul, 5:45 PM Archit Organosys - Quaterly Results 12 May, 7:14 PM Archit Organosys - Quaterly Results 12 May, 7:14 PM Archit Organosys informs about loss of share certificates 21 Jan, 3:25 PM Archit Organosys informs about loss of share certificates 9 Dec, 4:14 PM Archit Organosys informs about loss of share certificates 26 Nov, 2:55 PM Archit Organosys gets nod to expand existing production capacity 22 Sep, 9:44 AM Archit Organosys informs about newspaper publication 25 Aug, 4:40 PM Archit Organosys informs about disclosure 14 Jun, 4:30 PM Archit Organosys informs about disclosure 1 Jun, 4:37 PM Archit Organosys informs about loss of certificate 21 Apr, 3:25 PM Archit Organosys informs about annual report 7 Sep, 3:38 PM

Archit Organosys Stock Price Analysis and Quick Research Report. Is Archit Organosys an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Archit Organosys stock price today is Rs 43.83. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Archit Organosys . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Archit Organosys has a PE ratio of 26.8089791424552 which is high and comparatively overvalued .

  • Share Price: - The current share price of Archit Organosys is Rs 43.83. One can use valuation calculators of ticker to know if Archit Organosys share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Archit Organosys has ROA of 2.8579 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Archit Organosys has a Current ratio of 1.2056 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Archit Organosys has a ROE of 5.2982 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Archit Organosys has a Debt to Equity ratio of 0.4001 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Archit Organosys has reported revenue growth of -11.419 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Archit Organosys for the current financial year is 5.95972838925925 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Archit Organosys is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Archit Organosys is Rs 1.6349 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Archit Organosys in Ticker for free. Also, one can get the intrinsic value of Archit Organosys by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Archit Organosys
X